Concepts (239)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endothelial Cells | 16 | 2020 | 59 | 1.460 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 12 | 2017 | 38 | 1.090 |
Why?
|
| Capillary Permeability | 11 | 2013 | 29 | 1.070 |
Why?
|
| Lung | 16 | 2017 | 153 | 0.960 |
Why?
|
| RNA, Long Noncoding | 2 | 2022 | 5 | 0.920 |
Why?
|
| Endothelium, Vascular | 8 | 2015 | 46 | 0.900 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2023 | 28 | 0.820 |
Why?
|
| Pulmonary Artery | 4 | 2022 | 33 | 0.630 |
Why?
|
| Mice | 21 | 2021 | 1249 | 0.560 |
Why?
|
| Animals | 27 | 2021 | 3311 | 0.550 |
Why?
|
| Intercellular Junctions | 2 | 2008 | 8 | 0.540 |
Why?
|
| Cell Membrane | 4 | 2013 | 87 | 0.540 |
Why?
|
| Platelet Membrane Glycoproteins | 2 | 2013 | 6 | 0.500 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2013 | 23 | 0.490 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2013 | 11 | 0.480 |
Why?
|
| Enzyme Activation | 2 | 2013 | 111 | 0.430 |
Why?
|
| Hypertension, Pulmonary | 4 | 2020 | 17 | 0.430 |
Why?
|
| rac1 GTP-Binding Protein | 2 | 2016 | 14 | 0.430 |
Why?
|
| Ceramides | 1 | 2013 | 14 | 0.420 |
Why?
|
| Platelet Activating Factor | 2 | 2013 | 8 | 0.410 |
Why?
|
| Sex Characteristics | 3 | 2022 | 86 | 0.380 |
Why?
|
| Endocytosis | 6 | 2015 | 16 | 0.350 |
Why?
|
| Caveolae | 7 | 2015 | 17 | 0.340 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2008 | 3 | 0.300 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2008 | 7 | 0.300 |
Why?
|
| Neuropeptides | 1 | 2008 | 22 | 0.300 |
Why?
|
| Albumins | 2 | 2005 | 18 | 0.260 |
Why?
|
| Nitric Oxide | 2 | 2005 | 73 | 0.250 |
Why?
|
| Humans | 22 | 2023 | 23569 | 0.240 |
Why?
|
| Neutrophils | 4 | 2009 | 93 | 0.240 |
Why?
|
| Nitric Oxide Synthase | 1 | 2005 | 43 | 0.240 |
Why?
|
| RNA, Small Interfering | 5 | 2017 | 76 | 0.230 |
Why?
|
| Mice, Knockout | 8 | 2021 | 283 | 0.220 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2023 | 5 | 0.210 |
Why?
|
| Cell Proliferation | 4 | 2020 | 165 | 0.200 |
Why?
|
| Neutrophil Infiltration | 3 | 2009 | 8 | 0.200 |
Why?
|
| Cells, Cultured | 7 | 2020 | 472 | 0.200 |
Why?
|
| Sex Chromosomes | 1 | 2022 | 2 | 0.190 |
Why?
|
| Disease Models, Animal | 3 | 2021 | 528 | 0.180 |
Why?
|
| Sepsis | 3 | 2009 | 112 | 0.180 |
Why?
|
| Phosphorylation | 2 | 2013 | 131 | 0.180 |
Why?
|
| Microscopy, Electron | 5 | 2013 | 61 | 0.170 |
Why?
|
| Actins | 2 | 2009 | 35 | 0.150 |
Why?
|
| Lung Diseases | 2 | 2017 | 43 | 0.150 |
Why?
|
| Microscopy, Fluorescence | 4 | 2013 | 69 | 0.150 |
Why?
|
| Caveolin 1 | 3 | 2007 | 10 | 0.150 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2015 | 16 | 0.140 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2015 | 22 | 0.140 |
Why?
|
| MAP Kinase Signaling System | 2 | 2019 | 35 | 0.140 |
Why?
|
| ets-Domain Protein Elk-1 | 2 | 2017 | 4 | 0.140 |
Why?
|
| Pyridones | 1 | 2017 | 11 | 0.140 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2017 | 35 | 0.140 |
Why?
|
| Vascular Remodeling | 1 | 2017 | 4 | 0.130 |
Why?
|
| SOS1 Protein | 1 | 2016 | 4 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 1 | 2016 | 12 | 0.130 |
Why?
|
| Bone and Bones | 1 | 2017 | 109 | 0.130 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2016 | 48 | 0.130 |
Why?
|
| Escherichia coli Infections | 3 | 2005 | 25 | 0.130 |
Why?
|
| Knee Injuries | 1 | 2017 | 127 | 0.120 |
Why?
|
| Basal Ganglia | 1 | 2015 | 13 | 0.120 |
Why?
|
| Scavenger Receptors, Class B | 1 | 2015 | 2 | 0.120 |
Why?
|
| Blood-Brain Barrier | 1 | 2015 | 34 | 0.120 |
Why?
|
| alpha 1-Antitrypsin | 1 | 2015 | 3 | 0.120 |
Why?
|
| Smad2 Protein | 1 | 2015 | 2 | 0.120 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2015 | 5 | 0.120 |
Why?
|
| Signal Transduction | 4 | 2015 | 402 | 0.120 |
Why?
|
| Down-Regulation | 2 | 2015 | 91 | 0.120 |
Why?
|
| beta Catenin | 1 | 2015 | 58 | 0.110 |
Why?
|
| Lung Neoplasms | 2 | 2017 | 543 | 0.110 |
Why?
|
| Apoptosis | 3 | 2015 | 198 | 0.110 |
Why?
|
| Cerebral Hemorrhage | 1 | 2015 | 104 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 3 | 2017 | 364 | 0.110 |
Why?
|
| Female | 5 | 2022 | 13266 | 0.110 |
Why?
|
| Cartilage, Articular | 1 | 2017 | 279 | 0.110 |
Why?
|
| Lipopolysaccharides | 3 | 2011 | 87 | 0.110 |
Why?
|
| Gene Knockdown Techniques | 4 | 2015 | 41 | 0.110 |
Why?
|
| Smoking | 1 | 2015 | 168 | 0.110 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2013 | 22 | 0.110 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2013 | 9 | 0.100 |
Why?
|
| Immunoblotting | 1 | 2013 | 54 | 0.100 |
Why?
|
| Osteoarthritis, Knee | 1 | 2017 | 299 | 0.100 |
Why?
|
| Liposomes | 1 | 2013 | 13 | 0.100 |
Why?
|
| Analysis of Variance | 1 | 2013 | 235 | 0.100 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 341 | 0.100 |
Why?
|
| Indoles | 2 | 2019 | 32 | 0.100 |
Why?
|
| Membrane Proteins | 3 | 2008 | 151 | 0.100 |
Why?
|
| Dynamin II | 1 | 2011 | 2 | 0.090 |
Why?
|
| Male | 9 | 2021 | 12776 | 0.090 |
Why?
|
| rho GTP-Binding Proteins | 2 | 2009 | 8 | 0.090 |
Why?
|
| rhoA GTP-Binding Protein | 2 | 2009 | 9 | 0.090 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2011 | 64 | 0.080 |
Why?
|
| Lim Kinases | 1 | 2009 | 1 | 0.080 |
Why?
|
| Endothelium | 1 | 2009 | 13 | 0.080 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2009 | 7 | 0.080 |
Why?
|
| Acute Lung Injury | 1 | 2009 | 18 | 0.080 |
Why?
|
| T-Lymphoma Invasion and Metastasis-inducing Protein 1 | 1 | 2008 | 2 | 0.080 |
Why?
|
| Myosin Light Chains | 1 | 2008 | 3 | 0.080 |
Why?
|
| Zonula Occludens-1 Protein | 1 | 2008 | 10 | 0.080 |
Why?
|
| NG-Nitroarginine Methyl Ester | 2 | 2005 | 7 | 0.080 |
Why?
|
| Protein Transport | 1 | 2008 | 29 | 0.080 |
Why?
|
| Blood Vessels | 2 | 2005 | 14 | 0.080 |
Why?
|
| Phosphoproteins | 1 | 2008 | 23 | 0.080 |
Why?
|
| Cadherins | 1 | 2008 | 30 | 0.070 |
Why?
|
| Antigens, CD | 1 | 2008 | 49 | 0.070 |
Why?
|
| Qb-SNARE Proteins | 2 | 2005 | 4 | 0.070 |
Why?
|
| Qc-SNARE Proteins | 2 | 2005 | 4 | 0.070 |
Why?
|
| Exocytosis | 1 | 2007 | 4 | 0.070 |
Why?
|
| Cell Membrane Permeability | 1 | 2007 | 51 | 0.070 |
Why?
|
| Blood-Air Barrier | 1 | 2007 | 1 | 0.070 |
Why?
|
| Guanine Nucleotide Dissociation Inhibitors | 1 | 2007 | 2 | 0.070 |
Why?
|
| NF-kappa B | 1 | 2007 | 104 | 0.070 |
Why?
|
| Mice, Transgenic | 3 | 2015 | 176 | 0.070 |
Why?
|
| Rats | 3 | 2019 | 624 | 0.070 |
Why?
|
| Mitochondria | 1 | 2007 | 55 | 0.070 |
Why?
|
| Qa-SNARE Proteins | 1 | 2005 | 5 | 0.060 |
Why?
|
| Coloring Agents | 1 | 2005 | 14 | 0.060 |
Why?
|
| Organometallic Compounds | 1 | 2005 | 17 | 0.060 |
Why?
|
| Escherichia coli | 1 | 2005 | 46 | 0.060 |
Why?
|
| Membrane Fusion | 1 | 2005 | 29 | 0.060 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2005 | 44 | 0.060 |
Why?
|
| Cholesterol | 1 | 2005 | 57 | 0.060 |
Why?
|
| CD11b Antigen | 1 | 2005 | 13 | 0.060 |
Why?
|
| Enzyme Inhibitors | 1 | 2005 | 115 | 0.060 |
Why?
|
| Proteins | 1 | 2004 | 54 | 0.060 |
Why?
|
| Cell Line | 2 | 2015 | 250 | 0.050 |
Why?
|
| CD18 Antigens | 1 | 2003 | 2 | 0.050 |
Why?
|
| Pulmonary Circulation | 1 | 2003 | 4 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 2003 | 89 | 0.050 |
Why?
|
| Gold Colloid | 1 | 2002 | 2 | 0.050 |
Why?
|
| Biological Transport, Active | 1 | 2002 | 11 | 0.050 |
Why?
|
| Cross-Linking Reagents | 1 | 2002 | 10 | 0.050 |
Why?
|
| Nitrates | 1 | 2002 | 9 | 0.050 |
Why?
|
| Tyrosine | 1 | 2002 | 22 | 0.050 |
Why?
|
| Perfusion | 1 | 2002 | 17 | 0.050 |
Why?
|
| Binding Sites | 1 | 2002 | 68 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 1 | 2002 | 95 | 0.050 |
Why?
|
| Pneumonia | 1 | 2003 | 69 | 0.050 |
Why?
|
| Myocardium | 1 | 2002 | 100 | 0.050 |
Why?
|
| Inflammation | 2 | 2015 | 237 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 2 | 2013 | 60 | 0.050 |
Why?
|
| RNA, Messenger | 2 | 2013 | 285 | 0.040 |
Why?
|
| Cell Movement | 2 | 2016 | 77 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2021 | 144 | 0.040 |
Why?
|
| Gene Expression Regulation | 2 | 2015 | 233 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 2 | 2011 | 114 | 0.040 |
Why?
|
| Pyrroles | 1 | 2019 | 23 | 0.040 |
Why?
|
| Hypoxia | 1 | 2019 | 30 | 0.040 |
Why?
|
| Biotin | 2 | 2011 | 7 | 0.040 |
Why?
|
| Glycosaminoglycans | 1 | 2017 | 18 | 0.030 |
Why?
|
| Hyaluronan Synthases | 1 | 2017 | 4 | 0.030 |
Why?
|
| Fibrosis | 1 | 2017 | 30 | 0.030 |
Why?
|
| Base Sequence | 2 | 2007 | 102 | 0.030 |
Why?
|
| Hyaluronic Acid | 1 | 2017 | 34 | 0.030 |
Why?
|
| Disease Progression | 1 | 2019 | 530 | 0.030 |
Why?
|
| Systole | 1 | 2017 | 13 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 2017 | 15 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2017 | 13 | 0.030 |
Why?
|
| Hypertrophy | 1 | 2017 | 22 | 0.030 |
Why?
|
| Time-Lapse Imaging | 1 | 2016 | 5 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2016 | 13 | 0.030 |
Why?
|
| A549 Cells | 1 | 2016 | 11 | 0.030 |
Why?
|
| Collagen | 1 | 2017 | 81 | 0.030 |
Why?
|
| Ubiquitination | 1 | 2016 | 15 | 0.030 |
Why?
|
| Lipids | 1 | 2017 | 45 | 0.030 |
Why?
|
| Pulmonary Edema | 2 | 2009 | 21 | 0.030 |
Why?
|
| Microscopy, Confocal | 2 | 2007 | 81 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2016 | 102 | 0.030 |
Why?
|
| Heart Ventricles | 1 | 2017 | 84 | 0.030 |
Why?
|
| Hyperesthesia | 1 | 2015 | 1 | 0.030 |
Why?
|
| Claudin-3 | 1 | 2015 | 1 | 0.030 |
Why?
|
| Crosses, Genetic | 1 | 2015 | 4 | 0.030 |
Why?
|
| Claudin-1 | 1 | 2015 | 2 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2016 | 114 | 0.030 |
Why?
|
| Transgenes | 1 | 2015 | 10 | 0.030 |
Why?
|
| Tight Junctions | 1 | 2015 | 19 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2015 | 22 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2015 | 35 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2016 | 248 | 0.030 |
Why?
|
| RNA Interference | 1 | 2015 | 36 | 0.030 |
Why?
|
| Binding, Competitive | 1 | 2015 | 21 | 0.030 |
Why?
|
| Cell Adhesion | 2 | 2005 | 31 | 0.030 |
Why?
|
| Homeostasis | 1 | 2015 | 65 | 0.030 |
Why?
|
| Seizures | 1 | 2015 | 67 | 0.030 |
Why?
|
| Cell Survival | 1 | 2015 | 100 | 0.030 |
Why?
|
| Ataxia | 1 | 2015 | 75 | 0.030 |
Why?
|
| Cytokines | 1 | 2015 | 206 | 0.030 |
Why?
|
| Helminth Proteins | 2 | 2005 | 14 | 0.030 |
Why?
|
| Glycoproteins | 2 | 2005 | 42 | 0.030 |
Why?
|
| Proteolysis | 1 | 2013 | 6 | 0.030 |
Why?
|
| Granzymes | 1 | 2013 | 7 | 0.030 |
Why?
|
| Cations | 1 | 2013 | 16 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2013 | 23 | 0.030 |
Why?
|
| Transfection | 1 | 2013 | 117 | 0.030 |
Why?
|
| Models, Animal | 1 | 2013 | 104 | 0.030 |
Why?
|
| Lung Injury | 1 | 2013 | 7 | 0.030 |
Why?
|
| src Homology Domains | 1 | 2011 | 2 | 0.020 |
Why?
|
| Clathrin | 1 | 2011 | 3 | 0.020 |
Why?
|
| Phenotype | 1 | 2013 | 261 | 0.020 |
Why?
|
| GTP Phosphohydrolases | 1 | 2011 | 6 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2011 | 132 | 0.020 |
Why?
|
| Chemotaxis | 1 | 2009 | 5 | 0.020 |
Why?
|
| rho-Associated Kinases | 1 | 2009 | 4 | 0.020 |
Why?
|
| Wiskott-Aldrich Syndrome Protein | 1 | 2009 | 2 | 0.020 |
Why?
|
| Actin-Related Protein 2-3 Complex | 1 | 2009 | 2 | 0.020 |
Why?
|
| Pseudopodia | 1 | 2009 | 5 | 0.020 |
Why?
|
| Brain | 1 | 2015 | 1215 | 0.020 |
Why?
|
| DNA Primers | 1 | 2007 | 49 | 0.020 |
Why?
|
| Biological Transport | 1 | 2007 | 38 | 0.020 |
Why?
|
| rho-Specific Guanine Nucleotide Dissociation Inhibitors | 1 | 2007 | 2 | 0.020 |
Why?
|
| Cytochromes c | 1 | 2007 | 11 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2007 | 15 | 0.020 |
Why?
|
| CD47 Antigen | 1 | 2005 | 1 | 0.020 |
Why?
|
| Class Ib Phosphatidylinositol 3-Kinase | 1 | 2005 | 1 | 0.020 |
Why?
|
| Bronchopulmonary Sequestration | 1 | 2005 | 2 | 0.020 |
Why?
|
| Integrin beta3 | 1 | 2005 | 3 | 0.020 |
Why?
|
| Cell-Free System | 1 | 2005 | 2 | 0.020 |
Why?
|
| Streptavidin | 1 | 2005 | 3 | 0.020 |
Why?
|
| SNARE Proteins | 1 | 2005 | 9 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2005 | 50 | 0.010 |
Why?
|
| Gram-Negative Bacteria | 1 | 2005 | 26 | 0.010 |
Why?
|
| Oxidants | 1 | 2005 | 27 | 0.010 |
Why?
|
| Edema | 1 | 2005 | 23 | 0.010 |
Why?
|
| Protein Binding | 1 | 2005 | 114 | 0.010 |
Why?
|
| Adult | 1 | 2015 | 7178 | 0.010 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2003 | 3 | 0.010 |
Why?
|
| Dynamins | 1 | 2003 | 4 | 0.010 |
Why?
|
| Cell Compartmentation | 1 | 2003 | 8 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2003 | 27 | 0.010 |
Why?
|
| Chemokine CXCL2 | 1 | 2003 | 2 | 0.010 |
Why?
|
| Aged | 1 | 2015 | 7586 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2003 | 78 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2003 | 30 | 0.010 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2003 | 14 | 0.010 |
Why?
|
| Chemokines | 1 | 2003 | 14 | 0.010 |
Why?
|
| Leukocytes | 1 | 2003 | 31 | 0.010 |
Why?
|
| Respiratory Burst | 1 | 2003 | 27 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2003 | 79 | 0.010 |
Why?
|
| Middle Aged | 1 | 2015 | 8155 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2003 | 315 | 0.010 |
Why?
|